Seplat Energy's CEO Roger Brown hosts London Capital Markets Day and focuses the strategy. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Media (AVCT)

Share Price Information for Avacta (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 129.00
Ask: 133.00
Change: 8.00 (6.50%)
Spread: 4.00 (3.10%)
Open: 126.00
High: 132.00
Low: 125.00
Yest. Close: 123.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

EXCLUSIVE: Alastair Smith, Avacta Group CEO gives an Operational Update

In an exclusive interview with London South East, the Avacta Group CEO Alastair Smith outlines his plans for future development, having raised 11.6M in August. Avacta are a UK-based AIM listed pre clinical biotech group. Affimers are Avacta's platform based alternative to current antibody technologies.

Affimers are proprietary to Avacta and are a disruptive technology which can be used to replace antibodies in a range of drug development applications, in diagnostics and in research. Affimers are small, simple and very robust, make an effective alternative to antibodies and are easy to commercialise. Avacta has two business units - one focused on drug development using its novel platform development, and specialising in immunocology/cancer therapy a hot area right now.

This started in 2015, and here it is absolutely critical to build the data packs that will generate licence deals around particular assets or the platform in general. This unit is based in Cambridge. The second unit is generating revenues around the diagnostic and research applications of the Affimer technology. 'On the reagents and diagnostics side we are now generating revenues and getting commercial traction. The technology absolutely works and there are 100's of examples. W

e are now looking to build revenues and make a profitable business unit' said Alastair. This unit is based in Weatherby in Yorkshire. 'We have a lot in the pipeline in terms of big partners evaluating the technology to ultimately take a licence deal to develop products and produce the royalty stream which is what we are after'.

Related Avacta Media

Hardman Healthcare Index - Life Sciences, where the smart money was in an 'exceptional' 2020

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.